| scholarly article | Q13442814 |
| P50 | author | Daniel E. Cook | Q55686348 |
| P2093 | author name string | Jeffrey C Murray | |
| Kelli K Ryckman | |||
| Oleg A Shchelochkov | |||
| Stanton L Berberich | |||
| P2860 | cites work | Flexible mixture modeling via the multivariate t distribution with the Box-Cox transformation: an alternative to the skew-t distribution | Q35572799 |
| Newborn screening fact sheets | Q36584844 | ||
| Seasonality in the incidence of congenital hypothyroidism in Japan: gender-specific patterns and correlation with temperature | Q36979285 | ||
| Metabolomics: a new tool for the neonatologist | Q37585165 | ||
| Metabolomics: the "new clinical chemistry" for personalized neonatal medicine. | Q37810849 | ||
| Altered metabolism and newborn screening using tandem mass spectrometry: lessons learned from the bench to bedside | Q37861816 | ||
| Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants | Q38499380 | ||
| Effect of temperature changes on the occurrence of congenital hypothyroidism. | Q38873067 | ||
| The magnitude and challenge of false-positive newborn screening test results | Q40757729 | ||
| Current status of neonatal screening for congenital adrenal hyperplasia | Q41595777 | ||
| Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen | Q43422183 | ||
| Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. | Q43654372 | ||
| Seasonality in the incidence of congenital hypothyroidism in Japan | Q44583534 | ||
| Determination of the reference range of endogenous plasma carnitines in healthy adults | Q45297336 | ||
| Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns | Q46143588 | ||
| Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight | Q46410815 | ||
| Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia | Q46533292 | ||
| The influence of amino-acid supplementation, gestational age and time on thyroxine levels in premature neonates | Q46743372 | ||
| Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots | Q46748361 | ||
| Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls | Q46754970 | ||
| Effects of two different doses of amino acid supplementation on growth and blood amino acid levels in premature neonates admitted to the neonatal intensive care unit: a randomized, controlled trial | Q46869023 | ||
| Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels | Q47319081 | ||
| Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen. | Q50730976 | ||
| Carnitine measurements in liver, muscle tissue, and blood in normal subjects. | Q51058230 | ||
| Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. | Q55067438 | ||
| Metabolomics in neonatology and pediatrics | Q57749240 | ||
| Abnormal frequency of delta F508 mutation in neonatal transitory hypertrypsinaemia | Q68289738 | ||
| Plasma carnitine compartment and red blood cell carnitine compartment of healthy adults | Q69258894 | ||
| Aetiology of congenital hypothyroidism in Finland | Q69950794 | ||
| Newborn screening for congenital adrenal hyperplasia | Q73869695 | ||
| False negative 17-hydroxyprogesterone screening in children with classical congenital adrenal hyperplasia | Q80362800 | ||
| Using tandem mass spectrometry for metabolic disease screening among newborns. A report of a work group | Q81098618 | ||
| Further studies on episodic occurrence of congenital dysgenetic hypothyroidism in Osaka, Japan | Q81473037 | ||
| 1H NMR-based metabolomic analysis of urine from preterm and term neonates | Q84216346 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 133-138 | |
| P577 | publication date | 2012-09-23 | |
| P1433 | published in | Clinical Biochemistry | Q5133749 |
| P1476 | title | Clinical and environmental influences on metabolic biomarkers collected for newborn screening | |
| P478 | volume | 46 |
| Q47713549 | A maternal high-fat diet during pregnancy and lactation, in addition to a postnatal high-fat diet, leads to metabolic syndrome with spatial learning and memory deficits: beneficial effects of resveratrol |
| Q93051752 | Advanced Maternal Age, Mode of Delivery, and Thyroid Hormone Levels in Chinese Newborns |
| Q51694341 | Analysis and interpretation of acylcarnitine profiles in dried blood spot and plasma of preterm and full-term newborns. |
| Q40222464 | Damaged goods?: an empirical cohort study of blood specimens collected 12 to 23 hours after birth in newborn screening in California. |
| Q96773742 | Does metabolomic profile differ with regard to birth weight? |
| Q90678769 | Ethnic Variability in Newborn Metabolic Screening Markers Associated with False-Positive Outcomes |
| Q38988536 | Female and male human babies have distinct blood metabolomic patterns |
| Q36770344 | Gestational dating by metabolic profile at birth: a California cohort study |
| Q55358916 | Initial Metabolic Profiles Are Associated with 7-Day Survival among Infants Born at 22-25 Weeks of Gestation. |
| Q34660271 | Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone |
| Q49170879 | Medium chain acyl-CoA dehydrogenase deficiency in a premature infant |
| Q33916772 | Metabolic heritability at birth: implications for chronic disease research |
| Q39317447 | Metabolomics of prematurity: analysis of patterns of amino acids, enzymes, and endocrine markers by categories of gestational age. |
| Q58108288 | Newborn Metabolic Profile Associated with Hyperbilirubinemia With and Without Kernicterus |
| Q100409287 | Newborn metabolic vulnerability profile identifies preterm infants at risk for mortality and morbidity |
| Q37004707 | Newborn screening for congenital adrenal hyperplasia in New York State |
| Q40058298 | Performance of a postnatal metabolic gestational age algorithm: a retrospective validation study among ethnic subgroups in Canada |
| Q36731296 | Predicting gestational age using neonatal metabolic markers |
| Q37273113 | Pregnancy-Related Changes of Amino Acid and Acylcarnitine Concentrations: The Impact of Obesity |
| Q39143928 | The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns |
Search more.